Generic placeholder image

Recent Patents on Cardiovascular Drug Discovery

Editor-in-Chief

ISSN (Print): 2212-3962
ISSN (Online): 1574-8901

Soluble Epoxide Hydrolase: A Novel Target for the Treatment of Hypertension

Author(s): Xiang Fang

Volume 1, Issue 1, 2006

Page: [67 - 72] Pages: 6

DOI: 10.2174/157489006775244227

Abstract

Epoxide hydrolases are a group of enzymes that convert the epoxide group of chemical compounds to corresponding diols by the addition of water. Soluble epoxide hydrolase (sEH, formerly referred to as cytosolic epoxide hydrolase), which is widely distributed in mammalian tissues, is the primary enzyme responsible for the conversion of epoxyeicosatrienoic acids (EETs), the bioactive lipid mediators formed from arachidonic acid by cytochrome P450 epoxygenase, to their corresponding diols. EETs, but not their diols, are endogenous anti-hypertensive eicosanoids. Disruption of the sEH gene in male mice decreases blood pressure, and inhibition of sEH decreases blood pressure in several experimental hypertensive models. Potent selective sEH inhibitors have been developed, and these sEH inhibitors have potential to become a novel class of anti-hypertensive drug.

Keywords: Soluble epoxide hydrolase, inhibitors, arachidonic acid, cytochrome P450, epoxyeicosatrienoic acids, hypertension, vascular tone


© 2024 Bentham Science Publishers | Privacy Policy